• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.

作者信息

Taboada Manuel, Caruezo Valentín, Naveira Alberto, Atanassoff Peter G

机构信息

Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago, Spain; Sanitary Research Institute of Santiago (FIDIS), Spain.

Department of Anesthesiology and Intensive Care Medicine, Clinical University Hospital of Santiago, Spain; Sanitary Research Institute of Santiago (FIDIS), Spain.

出版信息

J Clin Anesth. 2020 Nov;66:109926. doi: 10.1016/j.jclinane.2020.109926. Epub 2020 May 26.

DOI:10.1016/j.jclinane.2020.109926
PMID:32474331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7247969/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc7/7247969/259fa23a293f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc7/7247969/259fa23a293f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5cc7/7247969/259fa23a293f/gr1_lrg.jpg

相似文献

1
Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.皮质类固醇与新型冠状病毒肺炎的高炎症期
J Clin Anesth. 2020 Nov;66:109926. doi: 10.1016/j.jclinane.2020.109926. Epub 2020 May 26.
2
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.基于 COVID-19、其他冠状病毒感染、流感、社区获得性肺炎和急性呼吸窘迫综合征的证据评估 COVID-19 中皮质类固醇的疗效和安全性：系统评价和荟萃分析。
CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14.
3
Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?螺内酯能否用于预防高血压患者的新型冠状病毒肺炎诱导的急性呼吸窘迫综合征？
Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E587-E588. doi: 10.1152/ajpendo.00136.2020.
4
Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.糖皮质激素治疗 2019 冠状病毒病相关急性呼吸窘迫综合征：一项倾向评分分析的队列研究。
Crit Care. 2020 Nov 10;24(1):643. doi: 10.1186/s13054-020-03340-4.
5
A rationale for targeting the P2X7 receptor in Coronavirus disease 19.靶向治疗 2019 冠状病毒病中 P2X7 受体的原理。
Br J Pharmacol. 2020 Nov;177(21):4990-4994. doi: 10.1111/bph.15138. Epub 2020 Jul 26.
6
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.精准皮质类固醇治疗对重症2019新型冠状病毒肺炎的潜在益处。
Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
7
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.用于新型冠状病毒肺炎急性呼吸窘迫综合征的神经肌肉阻滞剂：一项多中心观察性研究
Crit Care. 2020 Jul 19;24(1):446. doi: 10.1186/s13054-020-03164-2.
8
Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.新型冠状病毒肺炎急性呼吸窘迫综合征中的皮质类固醇：大流行期间的证据与希望
JAMA. 2020 Oct 6;324(13):1292-1295. doi: 10.1001/jama.2020.16747.
9
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?病毒大流行中的吸入性糖皮质激素：治疗新型冠状病毒肺炎（COVID-19）的方法？
Lancet Respir Med. 2020 Sep;8(9):846-847. doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.
10
Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?新冠病毒肺炎合并急性呼吸窘迫综合征患者的纤维蛋白溶解疗法：这是一种可行的方法吗？
J Trauma Acute Care Surg. 2020 Dec;89(6):e187-e188. doi: 10.1097/TA.0000000000002931.

引用本文的文献

1
Dexamethasone disrupts intracellular pH homeostasis to delay coronavirus infectious bronchitis virus cell entry via sodium hydrogen exchanger 3 activation.地塞米松通过激活钠氢交换体3破坏细胞内pH稳态，从而延迟冠状病毒传染性支气管炎病毒进入细胞。
J Virol. 2025 Jun 17;99(6):e0189424. doi: 10.1128/jvi.01894-24. Epub 2025 May 9.
2
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey.L-精氨酸联合维生素 C 可改善长新冠症状：林肯调查。
Pharmacol Res. 2022 Sep;183:106360. doi: 10.1016/j.phrs.2022.106360. Epub 2022 Jul 19.
3
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis.

本文引用的文献

1
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.新冠病毒疾病在自然状态和免疫抑制状态下：一项临床治疗分期建议。
J Heart Lung Transplant. 2020 May;39(5):405-407. doi: 10.1016/j.healun.2020.03.012. Epub 2020 Mar 20.
2
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management.国家传染病研究所“L. 斯帕兰扎尼”，意大利康复中心。新型冠状病毒肺炎临床管理建议。
Infect Dis Rep. 2020 Mar 16;12(1):8543. doi: 10.4081/idr.2020.8543. eCollection 2020 Feb 25.
3
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
用于治疗住院 COVID-19 患者的皮质类固醇治疗方案的疗效和安全性：一项荟萃分析。
Future Virol. 2022 Jul;17(7):463-489. doi: 10.2217/fvl-2021-0244. Epub 2022 Jun 3.
4
COVID-19 and erythrocrine function: The roller coaster and danger.COVID-19 与红细胞功能：过山车与危险。
Int J Immunopathol Pharmacol. 2022 Jan-Dec;36:3946320221103151. doi: 10.1177/03946320221103151.
5
Cell therapy in patients with COVID-19 using Wharton's jelly mesenchymal stem cells: a phase 1 clinical trial.使用牙髓间充质干细胞治疗 COVID-19 患者：一项 1 期临床试验。
Stem Cell Res Ther. 2021 Jul 16;12(1):410. doi: 10.1186/s13287-021-02483-7.
6
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.功能性 ACE2 缺乏导致 COVID-19 病理生理学中血管紧张素失衡。
Rev Endocr Metab Disord. 2022 Apr;23(2):151-170. doi: 10.1007/s11154-021-09663-z. Epub 2021 Jul 1.
7
It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?是时候在合适的时间窗内基于新冠病毒感染的病理生理学考虑一种抗炎疗法了吗？
Arch Med Sci. 2021 Feb 26;17(2):546-550. doi: 10.5114/aoms/130647. eCollection 2021.
8
Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study.COVID-19 重症患者的皮质类固醇治疗：一项倾向评分匹配研究。
Expert Rev Respir Med. 2021 Apr;15(4):543-552. doi: 10.1080/17476348.2021.1856659. Epub 2021 Feb 1.
9
Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.COVID-19 的预防和治疗：聚焦干扰素、氯喹/羟氯喹、阿奇霉素和疫苗。
Biomed Pharmacother. 2021 Jan;133:111008. doi: 10.1016/j.biopha.2020.111008. Epub 2020 Nov 11.
10
COVID-19 in China: From epidemiology to treatment (Review).中国的2019冠状病毒病：从流行病学到治疗（综述）
Exp Ther Med. 2020 Dec;20(6):223. doi: 10.3892/etm.2020.9353. Epub 2020 Oct 15.
与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
4
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.地塞米松治疗急性呼吸窘迫综合征：一项多中心、随机对照试验。
Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.
5
An Exploratory Reanalysis of the Randomized Trial on Efficacy of Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome.急性呼吸窘迫综合征后期皮质激素作为抢救治疗疗效的随机试验的探索性再分析
Crit Care Med. 2018 Jun;46(6):884-891. doi: 10.1097/CCM.0000000000003021.